The Runx2 Osteogenic Transcription Factor Regulates Matrix Metalloproteinase 9 in Bone Metastatic Cancer Cells and Controls Cell Invasion

REFERENCES

• Aalinkeel, R., M. P. Nair, G. Sufrin, S. D. Mahajan, K. C. Chadha, R. P. Chawda, and S. A. Schwartz. 2004. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Cancer Res. 64:5311–5321.
   PubMed Web of Science ®Google Scholar
• Afzal, F., J. Pratap, K. Ito, Y. Ito, J. L. Stein, A. J. van Wijnen, G. S. Stein, J. B. Lian, and A. Javed. 2005. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J. Cell. Physiol. 204:63–72.
   PubMedGoogle Scholar
• Amorino, G. P., and R. L. Hoover. 1998. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am. J. Pathol. 152:199–207.
   PubMed Web of Science ®Google Scholar
• Banerjee, C., L. R. McCabe, J.-Y. Choi, S. W. Hiebert, J. L. Stein, G. S. Stein, and J. B. Lian. 1997. Runt homology domain proteins in osteoblast differentiation: AML-3/CBFA1 is a major component of a bone specific complex. J. Cell. Biochem. 66:1–8.
   PubMed Web of Science ®Google Scholar
• Barnes, G. L., K. E. Hebert, M. Kamal, A. Javed, T. A. Einhorn, J. B. Lian, G. S. Stein, and L. C. Gerstenfeld. 2004. Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases associated osteolytic disease. Cancer Res. 64:4506–4513.
   PubMedGoogle Scholar
• Barnes, G. L., A. Javed, S. M. Waller, M. H. Kamal, K. E. Hebert, M. Q. Hassan, A. Bellahcene, A. J. van Wijnen, M. F. Young, J. B. Lian, G. S. Stein, and L. C. Gerstenfeld. 2003. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res. 63:2631–2637.
   PubMed Web of Science ®Google Scholar
• Bertrand-Philippe, M., R. G. Ruddell, M. J. Arthur, J. Thomas, N. Mungalsingh, and D. A. Mann. 2004. Regulation of tissue inhibitor of metalloproteinase 1 gene transcription by RUNX1 and RUNX2. J. Biol. Chem. 279:24530–24539.
   PubMedGoogle Scholar
• Blyth, K., E. R. Cameron, and J. C. Neil. 2005. The runx genes: gain or loss of function in cancer. Nat. Rev. Cancer 5:376–387.
   PubMed Web of Science ®Google Scholar
• Blyth, K., A. Terry, N. Mackay, F. Vaillant, M. Bell, E. R. Cameron, J. C. Neil, and M. Stewart. 2001. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging. Oncogene 20:295–302.
   PubMed Web of Science ®Google Scholar
• Brubaker, K. D., R. L. Vessella, L. G. Brown, and E. Corey. 2003. Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function. Prostate 56:13–22.
   PubMedGoogle Scholar
• Choi, J.-Y., J. Pratap, A. Javed, S. K. Zaidi, L. Xing, E. Balint, S. Dalamangas, B. Boyce, A. J. van Wijnen, J. B. Lian, J. L. Stein, S. N. Jones, and G. S. Stein. 2001. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc. Natl. Acad. Sci. USA 98:8650–8655.
   PubMed Web of Science ®Google Scholar
• Claffey, K. P., and G. S. Robinson. 1996. Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev. 15:165–176.
   PubMed Web of Science ®Google Scholar
• Coussens, L. M., B. Fingleton, and L. M. Matrisian. 2002. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295:2387–2392.
   PubMed Web of Science ®Google Scholar
• D'Alonzo, R. C., N. Selvamurugan, G. Karsenty, and N. C. Partridge. 2002. Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J. Biol. Chem. 277:816–822.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Dittmer, J. 2003. The biology of the Ets1 proto-oncogene. Mol. Cancer 2:29.
   PubMedGoogle Scholar
• Ducy, P., M. Starbuck, M. Priemel, J. Shen, G. Pinero, V. Geoffroy, M. Amling, and G. Karsenty. 1999. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13:1025–1036.
   PubMed Web of Science ®Google Scholar
• Ducy, P., R. Zhang, V. Geoffroy, A. L. Ridall, and G. Karsenty. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747–754.
   PubMed Web of Science ®Google Scholar
• Egeblad, M., and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2:161–174.
   PubMed Web of Science ®Google Scholar
• Fini, M. E., J. D. Bartlett, M. Matsubara, W. B. Rinehart, M. K. Mody, M. T. Girard, and M. Rainville. 1994. The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription. J. Biol. Chem. 269:28620–28628.
   PubMed Web of Science ®Google Scholar
• Galindo, M., J. Pratap, D. W. Young, H. Hovhannisyan, H. J. Im, J. Y. Choi, J. B. Lian, J. L. Stein, G. S. Stein, and A. J. van Wijnen. 2005. The bone-specific expression of RUNX2 oscillates during the cell cycle to support a G1 related anti-proliferative function in osteoblasts. J. Biol. Chem. 280:20274–20285.
   PubMed Web of Science ®Google Scholar
• Gutierrez, S., J. Liu, A. Javed, M. Montecino, G. S. Stein, J. B. Lian, and J. L. Stein. 2004. The vitamin D response element in the distal osteocalcin promoter contributes to chromatin organization of the proximal regulatory domain. J. Biol. Chem. 279:43581–43588.
   PubMedGoogle Scholar
• Hess, J., D. Porte, C. Munz, and P. Angel. 2001. AP-1 and Cbfa/Runt physically interact and regulate PTH-dependent MMP13 expression in osteoblasts through a new OSE2/AP-1 composite element. J. Biol. Chem. 276:20029–20038.
   PubMed Web of Science ®Google Scholar
• Hiratsuka, S., K. Nakamura, S. Iwai, M. Murakami, T. Itoh, H. Kijima, J. M. Shipley, R. M. Senior, and M. Shibuya. 2002. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2:289–300.
   PubMed Web of Science ®Google Scholar
• Inman, C. K., and P. Shore. 2003. The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. J. Biol. Chem. 278:48684–48689.
   PubMedGoogle Scholar
• Javed, A., G. L. Barnes, J. Pratap, T. Antkowiak, L. C. Gerstenfeld, A. J. van Wijnen, J. L. Stein, J. B. Lian, and G. S. Stein. 2005. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc. Natl. Acad. Sci. USA 102:1454–1459.
   PubMedGoogle Scholar
• Javed, A., S. Gutierrez, M. Montecino, A. J. van Wijnen, J. L. Stein, G. S. Stein, and J. B. Lian. 1999. Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization. Mol. Cell. Biol. 19:7491–7500.
   PubMed Web of Science ®Google Scholar
• Javed, A., M. van Rees, A. J. van Wijnen, J. L. Stein, G. S. Stein, and J. B. Lian. 1999. C/EBP family members are expressed in osteoblasts and are involved in regulation of osteocalcin gene transcription. J. Bone Miner. Res. 14:S469.
   Google Scholar
• Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R. T. Bronson, Y.-H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki, and T. Kishimoto. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755–764.
   PubMed Web of Science ®Google Scholar
• Lengner, C. J., H. Drissi, J.-Y. Choi, A. J. van Wijnen, J. L. Stein, G. S. Stein, and J. B. Lian. 2002. Activation of the bone related Runx2/Cbfa1 promoter in mesenchymal condensations and developing chondrocytes of the axial skeleton. Mech. Dev. 114:167–170.
   PubMed Web of Science ®Google Scholar
• Levanon, D., D. Bettoun, C. Harris-Cerruti, E. Woolf, V. Negreanu, R. Eilam, Y. Bernstein, D. Goldenberg, C. Xiao, M. Fliegauf, E. Kremer, F. Otto, O. Brenner, A. Lev-Tov, and Y. Groner. 2002. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 21:3454–3463.
   PubMed Web of Science ®Google Scholar
• Li, Q. L., K. Ito, C. Sakakura, H. Fukamachi, K. Inoue, X. Z. Chi, K. Y. Lee, S. Nomura, C. W. Lee, S. B. Han, H. M. Kim, W. J. Kim, H. Yamamoto, N. Yamashita, T. Yano, T. Ikeda, S. Itohara, J. Inazawa, T. Abe, A. Hagiwara, H. Yamagishi, A. Ooe, A. Kaneda, T. Sugimura, T. Ushijima, S. C. Bae, and Y. Ito. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109:113–124.
   PubMed Web of Science ®Google Scholar
• Lian, J. B., A. Javed, S. K. Zaidi, C. Lengner, M. Montecino, A. J. van Wijnen, J. L. Stein, and G. S. Stein. 2004. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit. Rev. Eukaryot. Gene Expr. 14:1–41.
   PubMed Web of Science ®Google Scholar
• Ma, Z., R. C. Shah, M. J. Chang, and E. N. Benveniste. 2004. Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol. Cell. Biol. 24:5496–5509.
   PubMed Web of Science ®Google Scholar
• Magid, R., T. J. Murphy, and Z. S. Galis. 2003. Expression of matrix metalloproteinase-9 in endothelial cells is differentially regulated by shear stress. Role of c-Myc. J. Biol. Chem. 278:32994–32999.
   PubMed Web of Science ®Google Scholar
• Mundy, G. R. 2002. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2:584–593.
   PubMed Web of Science ®Google Scholar
• Ogawa, S., H. Harada, M. Fujiwara, S. Tagashira, T. Katsumata, and H. Takada. 2000. Cbfa1, an essential transcription factor for bone formation, is expressed in testis from the same promoter used in bone. DNA Res. 7:181–185.
   PubMedGoogle Scholar
• O'Keefe, R. J., and T. A. Guise. 2003. Molecular mechanisms of bone metastasis and therapeutic implications. Clin. Orthop. Relat. Res. 2003(Suppl.):S100–S104.
   Google Scholar
• Okuda, T., J. van Deursen, S. W. Hiebert, G. Grosveld, and J. R. Downing. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321–330.
   PubMed Web of Science ®Google Scholar
• Ortega, N., D. J. Behonick, and Z. Werb. 2004. Matrix remodeling during endochondral ossification. Trends Cell Biol. 14:86–93.
   PubMed Web of Science ®Google Scholar
• Otto, F., H. Kanegane, and S. Mundlos. 2002. Mutations in the RUNX2 gene in patients with cleidocranial dysplasia. Hum. Mutat. 19:209–216.
   PubMed Web of Science ®Google Scholar
• Paredes, R., G. Arriagada, F. Cruzat, J. Olate, A. van Wijnen, J. Lian, G. Stein, J. Stein, and M. Montecino. 2004. The Runx2 transcription factor plays a key role in the 1α,25-dihydroxy vitamin D3-dependent upregulation of the rat osteocalcin (OC) gene expression in osteoblastic cells. J. Steroid Biochem. Mol. Biol. 89-90:269–271.
   PubMedGoogle Scholar
• Porte, D., J. Tuckermann, M. Becker, B. Baumann, S. Teurich, T. Higgins, M. J. Owen, M. Schorpp-Kistner, and P. Angel. 1999. Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 18:667–678.
   PubMed Web of Science ®Google Scholar
• Pratap, J., M. Galindo, S. K. Zaidi, D. Vradii, B. M. Bhat, J. A. Robinson, J.-Y. Choi, T. Komori, J. L. Stein, J. B. Lian, G. S. Stein, and A. J. van Wijnen. 2003. Cell growth regulatory role of Runx2 during proliferative expansion of pre-osteoblasts. Cancer Res. 63:5357–5362.
   PubMed Web of Science ®Google Scholar
• Quesada, A. R., M. M. Barbacid, E. Mira, P. Fernandez-Resa, G. Marquez, and M. Aracil. 1997. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases. Clin. Exp. Metastasis 15:26–32.
   PubMedGoogle Scholar
• Reponen, P., C. Sahlberg, C. Munaut, I. Thesleff, and K. Tryggvason. 1994. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J. Cell Biol. 124:1091–1102.
   PubMed Web of Science ®Google Scholar
• Riminucci, M., A. Corsi, K. Peris, L. W. Fisher, S. Chimenti, and P. Bianco. 2003. Coexpression of bone sialoprotein (BSP) and the pivotal transcriptional regulator of osteogenesis, Cbfa1/Runx2, in malignant melanoma. Calcif. Tissue Int. 73:281–289.
   PubMed Web of Science ®Google Scholar
• Sanceau, J., S. Truchet, and B. Bauvois. 2003. Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells. J. Biol. Chem. 278:36537–36546.
   PubMed Web of Science ®Google Scholar
• Satake, M., S. Nomura, Y. Yamaguchi-Iwai, Y. Takahama, Y. Hashimoto, M. Niki, Y. Kitamura, and Y. Ito. 1995. Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development. Mol. Cell. Biol. 15:1662–1670.
   PubMed Web of Science ®Google Scholar
• Sato, H., and M. Seiki. 1993. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8:395–405.
   PubMed Web of Science ®Google Scholar
• Selvamurugan, N., S. Kwok, and N. C. Partridge. 2004. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells. J. Biol. Chem. 279:27764–27773.
   PubMedGoogle Scholar
• Selvamurugan, N., and N. C. Partridge. 2000. Constitutive expression and regulation of collagenase-3 in human breast cancer cells. Mol. Cell Biol. Res. Commun. 3:218–223.
   PubMedGoogle Scholar
• Selvamurugan, N., M. R. Pulumati, D. R. Tyson, and N. C. Partridge. 2000. Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1. J. Biol. Chem. 275:5037–5042.
   PubMed Web of Science ®Google Scholar
• Stein, G. S., S. K. Zaidi, C. D. Braastad, M. Montecino, A. J. van Wijnen, J.-Y. Choi, J. L. Stein, J. B. Lian, and A. Javed. 2003. Functional architecture of the nucleus: organizing the regulatory machinery for gene expression, replication and repair. Trends Cell Biol. 13:584–592.
   PubMedGoogle Scholar
• Sun, L., M. Vitolo, and A. Passaniti. 2001. Runt-related gene 2 in endothelial cells: inducible expression and specific regulation of cell migration and invasion. Cancer Res. 61:4994–5001.
   PubMed Web of Science ®Google Scholar
• Takahra, T., D. E. Smart, F. Oakley, and D. A. Mann. 2004. Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1. Int. J. Biochem. Cell Biol. 36:353–363.
   PubMed Web of Science ®Google Scholar
• Van den Steen, P. E., B. Dubois, I. Nelissen, P. M. Rudd, R. A. Dwek, and G. Opdenakker. 2002. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37:375–536.
   PubMed Web of Science ®Google Scholar
• Vu, T. H., J. M. Shipley, G. Bergers, J. E. Berger, J. A. Helms, D. Hanahan, S. D. Shapiro, R. M. Senior, and Z. Werb. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411–422.
   PubMed Web of Science ®Google Scholar
• Wucherpfennig, A. L., Y. P. Li, W. G. Stetler-Stevenson, A. E. Rosenberg, and P. Stashenko. 1994. Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts. J. Bone Miner. Res. 9:549–556.
   PubMedGoogle Scholar
• Yang, J., K. Fizazi, S. Peleg, C. R. Sikes, A. K. Raymond, N. Jamal, M. Hu, M. Olive, L. A. Martinez, C. G. Wood, C. J. Logothetis, G. Karsenty, and N. M. Navone. 2001. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway. Cancer Res. 61:5652–5659.
   PubMedGoogle Scholar
• Yergeau, D. A., C. J. Hetherington, Q. Wang, P. Zhang, A. H. Sharpe, M. Binder, M. Marin-Padilla, D. G. Tenen, N. A. Speck, and D. E. Zhang. 1997. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet. 15:303–306.
   PubMed Web of Science ®Google Scholar
• Yeung, F., W. K. Law, C. H. Yeh, J. J. Westendorf, Y. Zhang, R. Wang, C. Kao, and L. W. Chung. 2002. Regulation of human osteocalcin promoter in hormone-independent human prostate cancer cells. J. Biol. Chem. 277:2468–2476.
   PubMedGoogle Scholar
• Yoshizaki, T., H. Sato, M. Furukawa, and J. S. Pagano. 1998. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc. Natl. Acad. Sci. USA 95:3621–3626.
   PubMed Web of Science ®Google Scholar
• Young, D. W., S. K. Zaidi, P. S. Furcinitti, A. Javed, A. J. van Wijnen, J. L. Stein, J. B. Lian, and G. S. Stein. 2004. Quantitative signature for architectural organization of regulatory factors using intranuclear informatics. J. Cell Sci. 117:4889–4896.
   PubMedGoogle Scholar
• Zelzer, E., D. J. Glotzer, C. Hartmann, D. Thomas, N. Fukai, S. Soker, and B. R. Olsen. 2001. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech. Dev. 106:97–106.
   PubMed Web of Science ®Google Scholar